Article
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis.
Journal of virology - 1 Apr 2000
Götte M, Arion D, Parniak M A, Wainberg M A
Abstract excerpt
Nucleoside analog chain terminators such as 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxy-3'-thiacytidine (3TC) represent an important class of drugs that are used in the clinic to inhibit the reverse transcriptase (RT) of human immunodeficiency virus type 1. Recent data have suggested that mutant enzymes associated with AZT resistance are capable of removing the chain-terminating residue with much greater...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
